ANTARES PHARMA, INC.
Matched from indexed company URL: ANTARES PHARMA INC
FDA Registration(s)#
Registration, FEI, Name table| Registration | FEI | Name | Status | Initial importer | Expiration year | Address |
|---|
| 2182861 | 2182861 | ANTARES PHARMA, INC. | 1 | N | 2026-01-01 | 12500 Whitewater Drive Minnetonka MN US 55343 |
Registered Device Listings#
Registration key, Listing key, Premarket submission table| Registration key | Listing key | Premarket submission | Device | Product code | Decision date |
|---|
| 75617 | 1483233103 | K991294 | MODIFICATION TO MEDI-JECT CORPORATION MEDI-JECTOR CHOICE NEEDLE-FREE INSULIN DELIVERY SYSTEM | KZE | 1999-04-23 |
| 75617 | 1741054900 | | | | |
Product Codes Associated With Registrations#
Product code, Registration listing records, Latest decision table| Product code | Registration listing records | Latest decision |
|---|
| KZE | 1 | 1999-04-23 |
NDC#
Antares Pharma, Inc.
Hyaluronidase
Antares Pharma, Inc.
methotrexate
Antares Pharma, Inc.
methotrexate
Antares Pharma, Inc.
methotrexate
Antares Pharma, Inc.
methotrexate
Antares Pharma, Inc.
methotrexate
Antares Pharma, Inc.
methotrexate
Antares Pharma, Inc.
methotrexate
Antares Pharma, Inc.
testosterone enanthate
Antares Pharma, Inc.
testosterone enanthate
Antares Pharma, Inc.
testosterone enanthate
Applications#
ANTARES PHARMA INC
ANTARES PHARMA INC
ANTARES PHARMA INC